@IreneNorstedt @EFPIA @IMI_JU @EU_Commission @ISC @GloPID_R @EPHA_EU @EMA_News @EUPHActs @TDRnews @EDCTP @ECRAID Thank you for your response. @EU_commission investment in health research incl. for the conditions mentioned is welcome. The question remains how @IMI_JU funding results in better patients' access to the end-products (as you write), this relates to price and availability.
06:03 - 13 Mar 2020